UroGen Pharma Ltd.

NASDAQ: URGN · Real-Time Price · USD
19.74
-0.34 (-1.69%)
At close: Aug 15, 2025, 3:59 PM
19.50
-1.22%
After-hours: Aug 15, 2025, 06:59 PM EDT

UroGen Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-126.87M -102.24M -109.78M -110.82M
Depreciation & Amortization
1.19M 1.71M 1.82M 1.77M
Stock-Based Compensation
13.11M 9.34M 10.58M 23.11M
Other Working Capital
2.45M 3.27M -5.24M -7.57M
Other Non-Cash Items
10.88M 11.48M 16.13M -1.18M
Deferred Income Tax
n/a n/a n/a 15.32M
Change in Working Capital
4.93M 3.34M -6.31M -13.11M
Operating Cash Flow
-96.77M -76.38M -87.56M -84.89M
Capital Expenditures
-295K -194K -254K -752K
Cash Acquisitions
n/a n/a -1.31M -4.82M
Purchase of Investments
-128.02M -49.83M -63.01M -51.9M
Sales Maturities Of Investments
107.7M 49.07M 64.32M 56.72M
Other Investing Acitivies
n/a n/a 1.31M 4.82M
Investing Cash Flow
-20.61M -953K 1.06M 4.07M
Debt Repayment
24.49M n/a 95.78M n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
18.96M 49.57M n/a 72.4M
Financial Cash Flow
194.62M 116.93M 97.13M 72.32M
Net Cash Flow
77.24M 39.6M 10.63M -8.5M
Free Cash Flow
-97.06M -76.57M -87.81M -85.64M